Icagen, Inc. - FORM S-1 - EX-23.1 - CONSENT OF REGISTERED PUBLIC ACCOUNTING FIRM - February 14, 2012

Attached files

file filename
S-1 - REGISRTAION STATEMENT - Icagen, Inc.fs12012_caldera.htm
EX-4.1 - FORM OF WARRANT TO PURCHASE COMMON STOCK - Icagen, Inc.fs12012ex4i_caldera.htm
EX-5.1 - OPINION OF GRACIN & MARLOW, LLP - Icagen, Inc.fs12012ex5i_caldera.htm
EX-10.1 - EMPLOYMENT AGREEMENT WITH DR. BENJAMIN WARNER - Icagen, Inc.fs12012ex10i_caldera.htm
EX-21.1 - LIST OF SUBSIDIARIES - Icagen, Inc.fs12012ex21i_caldera.htm
EX-4.4 - LIST OF WARRANT HOLDERS - Icagen, Inc.fs12012ex4iv_caldera.htm
EX-4.2 - PROMISSORY NOTE - Icagen, Inc.fs12012ex4ii_caldera.htm
EX-3.4 - BY-LAWS - Icagen, Inc.fs12012ex3iv_caldera.htm
EX-3.2 - FIRST AMENDMENT TO CERTIFICATE OF INCORPORATION DATED - Icagen, Inc.fs12012ex3ii_caldera.htm
EX-3.3 - CERTIFICATE OF DESIGNATIONS - Icagen, Inc.fs12012ex3iii_caldera.htm
EX-10.2 - EMPLOYMENT AGREEMENT WITH LORI PETERSON - Icagen, Inc.fs12012ex10ii_caldera.htm
EX-10.6 - OEM AGREEMENT - Icagen, Inc.fs12012ex10vi_caldera.htm
EX-10.3 - EXCLUSIVE PATENT LICENSE AGREEMENT - Icagen, Inc.fs12012ex10iii_caldera.htm
EX-3.1 - CERTIFICATE OF INCORPORATION DATED NOVEMBER 12, 2003 - Icagen, Inc.fs12012ex3i_caldera.htm
EX-10.5 - AMENDMENT NO. 1 TO PARTICIPATION AGREEMENT - Icagen, Inc.fs12012ex10v_caldera.htm
EX-4.3 - STOCK OPTION PLAN - Icagen, Inc.fs12012ex4iii_caldera.htm
EX-10.4 - PROJECT PARTICIPATION AGREEMENT - Icagen, Inc.fs12012ex10iv_caldera.htm
 
Exhibit 23.1
 

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT
 
We consent to the use in this Registration Statement on Form S-1, for Caldera Pharmaceuticals, Inc. of our report dated February 13, 2012, relating to the consolidated balance sheets of Caldera Pharmaceuticals, Inc. as of December 31, 2010 and 2009, and the related consolidated statements of operations, stockholders’ deficit and cash flows for the years ended December 31, 2010 and 2009. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
 
 
/s/Sherb & Co., LLP
 
Boca Raton, Florida
February 14, 2012

Icagen, Inc. Reports

Also read